Tin tức & Cập nhật

Do antiemetic drugs prevent chemotherapy-induced nausea, vomiting in cancer patients?
Do antiemetic drugs prevent chemotherapy-induced nausea, vomiting in cancer patients?
11 Oct 2023
ICI-related adverse events tied to longer survival in metastatic NSCLC
ICI-related adverse events tied to longer survival in metastatic NSCLC
08 Oct 2023 bởiStephen Padilla

Immune-related adverse events (irAEs) are more likely to develop in metastatic nonsmall cell lung cancer (NSCLC) patients with certain prognostic characteristics, suggests a study. Interestingly, those who develop irAEs benefit from a much longer overall survival (OS) and time to next treatment when mitigating immortal time bias.

ICI-related adverse events tied to longer survival in metastatic NSCLC
08 Oct 2023
Canakinumab improves survival in advanced NSCLC
Canakinumab improves survival in advanced NSCLC
07 Oct 2023 bởiStephen Padilla

Treatment with canakinumab appears beneficial to patients with advanced nonsmall cell lung cancer (NSCLC) with low T-cell infiltration (ie, low total count or immune desert phenotype), results of predefined exploratory biomarker analyses from the CANOPY-1 have shown.

Canakinumab improves survival in advanced NSCLC
07 Oct 2023